The ML Cu250; clinical experience in Belgium and The Netherlands

The ML Cu250, a copper‐wired intrauterine contraceptive device, was inserted in 5736 women, at interval or immediately after delivery of the placenta. Forty‐eight months after insertion, the data covering 196214 woman‐months were computerized and then analysed according to the life‐table method. Int...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BJOG : an international journal of obstetrics and gynaecology 1982-09, Vol.89 (Suppl 4), p.51-53
Hauptverfasser: THIERY, M., KETS, H., PAS, H., OS, W., DOMBROWICZ, N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 53
container_issue Suppl 4
container_start_page 51
container_title BJOG : an international journal of obstetrics and gynaecology
container_volume 89
creator THIERY, M.
KETS, H.
PAS, H.
OS, W.
DOMBROWICZ, N.
description The ML Cu250, a copper‐wired intrauterine contraceptive device, was inserted in 5736 women, at interval or immediately after delivery of the placenta. Forty‐eight months after insertion, the data covering 196214 woman‐months were computerized and then analysed according to the life‐table method. Interval insertion was more effective than postplacental insertion. In nulligravidas interval insertion did not increase the removal rates for other medical reasons (including pelvic inflammatory disease), but expulsion rates were higher relative to the entire group (a variety of parities).
doi_str_mv 10.1111/j.1471-0528.1982.tb15071.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80245805</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80245805</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3681-fa4665b93a661e8c5b9f6422a906e2429d4565cf74c162a183dfa4531a2703893</originalsourceid><addsrcrecordid>eNqVkE1PwzAMhiMEGjD4CUgRB24t-WjSFIQEm_jUYJdxjrLUZZnabTSr2P49Kat2xxfbev3a1oPQJSUxDXE9j2mS0ogIpmKaKRavp1SQlMabA3Sylw7_ahIRztQxOvV-TgiVjPAe6kmVUSb5CbqfzAC_j_CwYYLcYlu6hbOmxLBZQe1gYQG7BR5A-eWaCptFjlvDB6xnUJeh9WfoqDClh_Mu99Hn0-Nk-BKNxs-vw4dRZLlUNCpMIqWYZtxISUHZUBYyYcxkRAJLWJYnQgpbpIkNPxqqeB4sglPDUsJVxvvoard3VS-_G_BrXTlvoQxPwLLxWhGWCEVEGLzZDdp66X0NhV7VrjL1VlOiW3x6rltGumWkW3y6w6c3wXzRXWmmFeR7a8cr6Hc7_ceVsP3HZj14GwvKfwEUW3wu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80245805</pqid></control><display><type>article</type><title>The ML Cu250; clinical experience in Belgium and The Netherlands</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>THIERY, M. ; KETS, H. ; PAS, H. ; OS, W. ; DOMBROWICZ, N.</creator><creatorcontrib>THIERY, M. ; KETS, H. ; PAS, H. ; OS, W. ; DOMBROWICZ, N.</creatorcontrib><description>The ML Cu250, a copper‐wired intrauterine contraceptive device, was inserted in 5736 women, at interval or immediately after delivery of the placenta. Forty‐eight months after insertion, the data covering 196214 woman‐months were computerized and then analysed according to the life‐table method. Interval insertion was more effective than postplacental insertion. In nulligravidas interval insertion did not increase the removal rates for other medical reasons (including pelvic inflammatory disease), but expulsion rates were higher relative to the entire group (a variety of parities).</description><identifier>ISSN: 1470-0328</identifier><identifier>ISSN: 0306-5456</identifier><identifier>EISSN: 1471-0528</identifier><identifier>DOI: 10.1111/j.1471-0528.1982.tb15071.x</identifier><identifier>PMID: 6891263</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Belgium ; Female ; Humans ; Intrauterine Devices, Copper - adverse effects ; Netherlands ; Postpartum Period ; Pregnancy ; Time Factors</subject><ispartof>BJOG : an international journal of obstetrics and gynaecology, 1982-09, Vol.89 (Suppl 4), p.51-53</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3681-fa4665b93a661e8c5b9f6422a906e2429d4565cf74c162a183dfa4531a2703893</citedby><cites>FETCH-LOGICAL-c3681-fa4665b93a661e8c5b9f6422a906e2429d4565cf74c162a183dfa4531a2703893</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1471-0528.1982.tb15071.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1471-0528.1982.tb15071.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6891263$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>THIERY, M.</creatorcontrib><creatorcontrib>KETS, H.</creatorcontrib><creatorcontrib>PAS, H.</creatorcontrib><creatorcontrib>OS, W.</creatorcontrib><creatorcontrib>DOMBROWICZ, N.</creatorcontrib><title>The ML Cu250; clinical experience in Belgium and The Netherlands</title><title>BJOG : an international journal of obstetrics and gynaecology</title><addtitle>Br J Obstet Gynaecol</addtitle><description>The ML Cu250, a copper‐wired intrauterine contraceptive device, was inserted in 5736 women, at interval or immediately after delivery of the placenta. Forty‐eight months after insertion, the data covering 196214 woman‐months were computerized and then analysed according to the life‐table method. Interval insertion was more effective than postplacental insertion. In nulligravidas interval insertion did not increase the removal rates for other medical reasons (including pelvic inflammatory disease), but expulsion rates were higher relative to the entire group (a variety of parities).</description><subject>Belgium</subject><subject>Female</subject><subject>Humans</subject><subject>Intrauterine Devices, Copper - adverse effects</subject><subject>Netherlands</subject><subject>Postpartum Period</subject><subject>Pregnancy</subject><subject>Time Factors</subject><issn>1470-0328</issn><issn>0306-5456</issn><issn>1471-0528</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1982</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkE1PwzAMhiMEGjD4CUgRB24t-WjSFIQEm_jUYJdxjrLUZZnabTSr2P49Kat2xxfbev3a1oPQJSUxDXE9j2mS0ogIpmKaKRavp1SQlMabA3Sylw7_ahIRztQxOvV-TgiVjPAe6kmVUSb5CbqfzAC_j_CwYYLcYlu6hbOmxLBZQe1gYQG7BR5A-eWaCptFjlvDB6xnUJeh9WfoqDClh_Mu99Hn0-Nk-BKNxs-vw4dRZLlUNCpMIqWYZtxISUHZUBYyYcxkRAJLWJYnQgpbpIkNPxqqeB4sglPDUsJVxvvoard3VS-_G_BrXTlvoQxPwLLxWhGWCEVEGLzZDdp66X0NhV7VrjL1VlOiW3x6rltGumWkW3y6w6c3wXzRXWmmFeR7a8cr6Hc7_ceVsP3HZj14GwvKfwEUW3wu</recordid><startdate>198209</startdate><enddate>198209</enddate><creator>THIERY, M.</creator><creator>KETS, H.</creator><creator>PAS, H.</creator><creator>OS, W.</creator><creator>DOMBROWICZ, N.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198209</creationdate><title>The ML Cu250; clinical experience in Belgium and The Netherlands</title><author>THIERY, M. ; KETS, H. ; PAS, H. ; OS, W. ; DOMBROWICZ, N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3681-fa4665b93a661e8c5b9f6422a906e2429d4565cf74c162a183dfa4531a2703893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1982</creationdate><topic>Belgium</topic><topic>Female</topic><topic>Humans</topic><topic>Intrauterine Devices, Copper - adverse effects</topic><topic>Netherlands</topic><topic>Postpartum Period</topic><topic>Pregnancy</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>THIERY, M.</creatorcontrib><creatorcontrib>KETS, H.</creatorcontrib><creatorcontrib>PAS, H.</creatorcontrib><creatorcontrib>OS, W.</creatorcontrib><creatorcontrib>DOMBROWICZ, N.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>BJOG : an international journal of obstetrics and gynaecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>THIERY, M.</au><au>KETS, H.</au><au>PAS, H.</au><au>OS, W.</au><au>DOMBROWICZ, N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The ML Cu250; clinical experience in Belgium and The Netherlands</atitle><jtitle>BJOG : an international journal of obstetrics and gynaecology</jtitle><addtitle>Br J Obstet Gynaecol</addtitle><date>1982-09</date><risdate>1982</risdate><volume>89</volume><issue>Suppl 4</issue><spage>51</spage><epage>53</epage><pages>51-53</pages><issn>1470-0328</issn><issn>0306-5456</issn><eissn>1471-0528</eissn><abstract>The ML Cu250, a copper‐wired intrauterine contraceptive device, was inserted in 5736 women, at interval or immediately after delivery of the placenta. Forty‐eight months after insertion, the data covering 196214 woman‐months were computerized and then analysed according to the life‐table method. Interval insertion was more effective than postplacental insertion. In nulligravidas interval insertion did not increase the removal rates for other medical reasons (including pelvic inflammatory disease), but expulsion rates were higher relative to the entire group (a variety of parities).</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>6891263</pmid><doi>10.1111/j.1471-0528.1982.tb15071.x</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1470-0328
ispartof BJOG : an international journal of obstetrics and gynaecology, 1982-09, Vol.89 (Suppl 4), p.51-53
issn 1470-0328
0306-5456
1471-0528
language eng
recordid cdi_proquest_miscellaneous_80245805
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection
subjects Belgium
Female
Humans
Intrauterine Devices, Copper - adverse effects
Netherlands
Postpartum Period
Pregnancy
Time Factors
title The ML Cu250; clinical experience in Belgium and The Netherlands
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T06%3A40%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20ML%20Cu250;%20clinical%20experience%20in%20Belgium%20and%20The%20Netherlands&rft.jtitle=BJOG%20:%20an%20international%20journal%20of%20obstetrics%20and%20gynaecology&rft.au=THIERY,%20M.&rft.date=1982-09&rft.volume=89&rft.issue=Suppl%204&rft.spage=51&rft.epage=53&rft.pages=51-53&rft.issn=1470-0328&rft.eissn=1471-0528&rft_id=info:doi/10.1111/j.1471-0528.1982.tb15071.x&rft_dat=%3Cproquest_cross%3E80245805%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80245805&rft_id=info:pmid/6891263&rfr_iscdi=true